Go offline with the Player FM app!
Personalised genetic insights: A revolution in papillary thyroid cancer
Manage episode 455771421 series 2680968
While the management of papillary thyroid cancer (PTC) is guided by recurrence risk assessment, current methods cannot accurately predict disease recurrence.
Professor Oliver Bathe and his collaborators at the University of Calgary, Canada, have developed a test that includes genetic data linked to recurrence. Together, they identified three molecular PTC subtypes, allowing more accurate risk assessment to guide clinical decision-making and treatment.
Read more in Research Features
Read the original research: doi.org/10.3389/fendo.2023.1220617
477 episodes
Manage episode 455771421 series 2680968
While the management of papillary thyroid cancer (PTC) is guided by recurrence risk assessment, current methods cannot accurately predict disease recurrence.
Professor Oliver Bathe and his collaborators at the University of Calgary, Canada, have developed a test that includes genetic data linked to recurrence. Together, they identified three molecular PTC subtypes, allowing more accurate risk assessment to guide clinical decision-making and treatment.
Read more in Research Features
Read the original research: doi.org/10.3389/fendo.2023.1220617
477 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.